Robert Jr. Moscato - Net Worth and Insider Trading

Robert Jr. Moscato Net Worth

The estimated net worth of Robert Jr. Moscato is at least $9,711 dollars as of 2024-05-23. Robert Jr. Moscato is the COO of Avalo Therapeutics Inc and owns about 900 shares of Avalo Therapeutics Inc (AVTX) stock worth over $9,711. Details can be seen in Robert Jr. Moscato's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert Jr. Moscato has not made any transactions after 2017-12-04 and currently still holds the listed stock(s).

Transaction Summary of Robert Jr. Moscato

To

Robert Jr. Moscato Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Jr. Moscato owns 2 companies in total, including Adhera Therapeutics Inc (ATRX) , and Avalo Therapeutics Inc (AVTX) .

Click here to see the complete history of Robert Jr. Moscato’s form 4 insider trades.

Insider Ownership Summary of Robert Jr. Moscato

Ticker Comapny Transaction Date Type of Owner
ATRX Adhera Therapeutics Inc 2018-06-18 CEO
AVTX Avalo Therapeutics Inc 2017-12-04 director & President and COO

Robert Jr. Moscato Latest Holdings Summary

Robert Jr. Moscato currently owns a total of 1 stock. Robert Jr. Moscato owns 900 shares of Avalo Therapeutics Inc (AVTX) as of December 4, 2017, with a value of $9,711.

Latest Holdings of Robert Jr. Moscato

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AVTX Avalo Therapeutics Inc 2017-12-04 900 10.79 9,711

Holding Weightings of Robert Jr. Moscato


Robert Jr. Moscato Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Jr. Moscato has made a total of 0 transactions in Avalo Therapeutics Inc (AVTX) over the past 5 years. The most-recent trade in Avalo Therapeutics Inc is the acquisition of 0 shares on December 4, 2017, which cost Robert Jr. Moscato around $504.

Insider Trading History of Robert Jr. Moscato

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Jr. Moscato Trading Performance

GuruFocus tracks the stock performance after each of Robert Jr. Moscato's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Jr. Moscato is 176.97%. GuruFocus also compares Robert Jr. Moscato's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Jr. Moscato within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert Jr. Moscato's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert Jr. Moscato

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 79.78
Relative Return to S&P 500(%) 76.58

Robert Jr. Moscato Ownership Network

Ownership Network List of Robert Jr. Moscato

No Data

Ownership Network Relation of Robert Jr. Moscato


Robert Jr. Moscato Owned Company Details

What does Adhera Therapeutics Inc do?

Who are the key executives at Adhera Therapeutics Inc?

Robert Jr. Moscato is the CEO of Adhera Therapeutics Inc. Other key executives at Adhera Therapeutics Inc include director & Chief Executive Officer Andrew Albert Kucharchuk , SVP Finance & Accounting Rhonda L. Stanley , and Chief Financial Officer Robert Eric Teague .

Adhera Therapeutics Inc (ATRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adhera Therapeutics Inc (ATRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adhera Therapeutics Inc (ATRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adhera Therapeutics Inc (ATRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adhera Therapeutics Inc Insider Transactions

No Available Data

Robert Jr. Moscato Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Jr. Moscato. You might contact Robert Jr. Moscato via mailing address: 400 Pratt Street, Suite 606, Baltimore Md 21202.

Discussions on Robert Jr. Moscato

No discussions yet.